الفهرس 
Vitamin D; General overviewOnly 14 pages are availabe for public view
 |  | from | 128 |  |  |
| | | from | 128 | | |
Abstract
ABSTRACT
Background: Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder, which can affect all members of a society, regardless of age, sex, race or socioeconomic status. Because of its high prevalence and chronic nature, it represents a significant economic burden. In fact, these patients have a relevant impairment of their quality of life, which limits their work productivity and daily social activities, especially when it is associated with other disorders, such as anxiety and depression.
Aim of the Work: The aim of this study is to evaluate the Impact of Vitamin D as a potential therapy for treatment of IBS in Egyptian patients.
Patients and Methods: The study was conducted on 90 Egyptian patients whose age is more than 18 years and have irritable bowel syndrome according to Room IV criteria.
Results: Irritable bowel syndrome (IBS) is among the most common gastrointestinal (GI) disorder, affecting around 8.8% of the population. It accounts for significant global morbidity and poor quality of life. It is usually suspected when someone suffers from abdominal pain and altered bowel habit without any identifiable organic cause. IBS cases amount to around 25%-50% of all GI referral cases as it is common in the community.
Conclusion: High prevalence of Vitamin D deficiency about Egyptian patients with IBS. There was a significant negative correlation between serum vitamin D and baseline IBSSS Vitamin D may be a potential therapy for treatment of IBS in Egyptian patients.